The first total synthesis of ganglioside GalNAc-GD1a, a target molecule for autoantibodies in Guillain-Barré syndrome.

Source:http://linkedlifedata.com/resource/pubmed/id/21469228

Chemistry 2011 May 9 17 20 5641-51

Download in:

View as

General Info

PMID
21469228